MPower by Rivalus Ingredients, Side Effects and Drug Interactions
Dietary Supplement Capsule Other Combinations
UPC 8 07156 00051 5 Match it to the barcode on your bottle
Summary: The HelloPharmacist Team’s Take
- Form
- Capsule
- Serving Size
- 1 Capsule
- Servings
- 63 per container
- Container Holds
- 126 Sustained-Release Capsules
What’s in it, whether it interacts with your drugs, its side effects, whether it works, and what our pharmacists would want you to know before you start it.
- What is MPower?A supplement from Rivalus with twelve active ingredients, in capsule form.
- Active Ingredients 5 plant ingredients such as Green Tea, Guarana and Yerba Mate, 1 fatty acid, 1 fat or oil and 5 others: KrebfuelGreen Tea extractGuaranaYerba MateCaffeine AnhydrousCampesterolRheosmin/Raspberry KetoneConjugated Linoleic AcidEvodiamineGinkgo leaf extractVinpocetineSiberian Rhodiola rosea Twelve active ingredients. Each one can interact with drugs or cause side effects on its own, so we check every one. The full Supplement Facts
- Drug Interactions 1,682 drugs have a documented interaction with this supplement; the most serious is rated major. Of those, 1,197 are single drugs and 485 are combination products (two or more drugs in one), each listed under its own name. Based on the 9 of its 12 ingredients we could check. Ask your pharmacist first if you take a drug in any of these categories, the most serious of the 82 on record:
- EphedrineMajor · 8 drugs
- Atorvastatin (Lipitor)Major · 3 drugs
- Nadolol (Corgard)Major · 2 drugs
- TalinololMajor · 1 drug
- Possible Side EffectsHeadache 4 ingredientsNausea 4 ingredientsTrouble sleeping 4 ingredientsDizziness 3 ingredientsJitteriness 3 ingredientsNervousness 3 ingredients +19 moreCombined from eight of its twelve active ingredients. Not studied in this exact product.
- Well documented Why
Does MPower work?
What It Is Marketed For
Body fat reduction and athletic performance
From the claims on the product’s label.
The Closest Use the Research Grades
Caffeine
Good studies support it.
Its ingredients have research behind other uses too:
- Mental alertness Caffeine
- Green Tea
- Ginkgo
- Cardiovascular disease (CVD) Green Tea
- Caffeine
- Ginkgo
These grades are for each ingredient, not this exact product, and never a promise it will work for you.
And 6 more graded uses, in what the research says- Low Why
- AllergensNone of its ingredient names point to a major food allergen, and the label text we have carries no allergen statement
- Barcode (UPC)8 07156 00051 5Match it to the barcode on your bottle to be sure this is your product. Not your product? Search for it here
Who Might Consider It
- People looking for body fat reduction and athletic performance, which is what it is marketed for. The closest use the research grades is athletic performance, rated Likely Effective.
- People who want it for mental alertness, hyperlipidemia, anxiety, cardiovascular disease (CVD) or another graded use: the other uses with research behind them. See each grade
- MPower may appeal to people who want a caffeine and botanical blend and who are not taking any of the medications listed above.
Who Should Be Careful
- Anyone taking ephedrine, nadolol, atorvastatin, talinolol, warfarin, or another medicine on that list should be careful, as should anyone with heart problems, high blood pressure, anxiety, or seizure disorders.
- Children and teens should limit caffeine, and pregnant or breastfeeding people should be cautious.
- Talk it over with your own doctor or pharmacist before starting.
More Before You Take It Show both answersHide Pregnancy and Breastfeeding The Label’s Directions
-
Pregnant or breastfeeding?
- Pregnancy Red Raspberry
- ! When red raspberry leaf is used orally in medicinal amounts throughout pregnancy or for self-treatment.
- Breastfeeding Red Raspberry
- When the fruit is used orally in amounts commonly found in foods.
- Pregnancy Green Tea
- ! When used orally in amounts providing more than 300 mg caffeine daily.
- Breastfeeding Green Tea
- ! When used orally in large amounts.
- Pregnancy Guarana
- ! When used orally in amounts over 300 mg daily.
- Breastfeeding Guarana
- ! When used orally in large amounts.
-
How does the label say to take it?
“Recommended Use: Dr. Burke (PhD) recommends 1 capsule in morning and 1 capsule in the afternoon for one week, then 2 capsules in morning and 2 capsules in the afternoon. On training days, take one serving 30-60 minutes before exercise. …”
The maker’s words. Your pharmacist or doctor may advise differently.
Everything the label says
From the label dated Feb 23, 2012: 9 of its 12 active ingredients were checked against our records; the other three are not in them yet. A summary of what is known, not a grade or a test of the product. How these ratings are computed
Ask Anything About This Supplement
Name a drug you take, or ask about side effects, ingredients or pregnancy.
AI answers come from this label and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, as soon as they can.
Got it — thank you!
A licensed pharmacist will answer as soon as they can. Keep an eye on your email (worth checking spam, just in case).
What’s Inside MPower by Rivalus
Twelve Active Ingredients, Each Checked on Its Own
A supplement is often several ingredients in one bottle, and each one can interact with drugs or cause side effects on its own. We check every one of them against our records.
- KrebfuelNot in our interaction records yet
- Green Tea extractDrug interactions on record, most serious: Major
- GuaranaDrug interactions on record, most serious: Major
- Yerba MateDrug interactions on record, most serious: Major
- Caffeine AnhydrousDrug interactions on record, most serious: Major
- CampesterolNot in our interaction records yet
- Rheosmin/Raspberry KetoneDrug interactions on record, most serious: Moderate
- Conjugated Linoleic AcidNot in our interaction records yet
And 4 more, each with its own card below.
The label gives an exact amount for 0 of its 12 active ingredients. Twelve are inside three proprietary blends, and the label gives one total for each, not how much of each ingredient is in it.
- 0 state an exact amount
- 12 have no amount of their own
- MITOLEAN (Combination) 822 mg in total · 5 ingredients, no amount for each
- p38BURN (Combination) 364 mg in total · 4 ingredients, no amount for each
- nFOCUS (Combination) 295 mg in total · 3 ingredients, no amount for each
This rates what the label tells you, not the quality of the product.
Supplement Facts
| Amount Per Serving | % Daily Value | |
|---|---|---|
| MITOLEAN (Combination) | 822 mg | † |
| KREBFUEL | † | |
| Lactate | † | |
| Pyruvate | † | |
| Citrate | † | |
| Fumarate | † | |
| Succinate | † | |
| Malate | † | |
| Octanol | † | |
| Gamma-Terpinene | † | |
| Terpinen-4-Ol | † | |
| Green Tea extract | † | |
| Guarana | † | |
| Yerba Mate | † | |
| Caffeine Anhydrous | † | |
| p38BURN (Combination) | 364 mg | † |
| Campesterol | † | |
| Rheosmin/Raspberry Ketone | † | |
| Conjugated Linoleic Acid | † | |
| Evodiamine | † | |
| nFOCUS (Combination) | 295 mg | † |
| Ginkgo leaf extract | † | |
| Vinpocetine | † | |
| Siberian Rhodiola rosea | † | |
Other ingredients: Gelatin, Magnesium Stearate, Silica, Microcrystalline Cellulose, Permeate
† Daily Value not established.
Daily Values for adults and children 4 or more years of age.
As the label prints it, from the NIH Dietary Supplement Label Database.
Each Ingredient and Its Drug Interactions
Tap one for more about it and its full guide. A drug can interact with this supplement through any one of them.
MPower lists 20 ingredients in total.
- Caffeine is the main stimulant here, and green tea, guarana, and yerba mate add more caffeine on top of it.
- Other ingredients include vinpocetine, Siberian rhodiola, pyruvate, succinate, lactate, malate, citrate, red raspberry, and ginkgo leaf extract, and several are on the list without interaction data we can share.
-
MITOLEAN (Combination) 822 mg Five ingredients inside it, each checked on its own
- KREBFUEL
- Green Tea extract 1,294 drugs
- Guarana 655 drugs
- Yerba Mate 1,087 drugs
- Caffeine Anhydrous 655 drugs
-
P38BURN (Combination) 364 mg Four ingredients inside it, each checked on its own
- Campesterol
- Rheosmin/Raspberry Ketone 135 drugs
- Conjugated Linoleic Acid
- Evodiamine
-
NFOCUS (Combination) 295 mg Three ingredients inside it, each checked on its own
- Ginkgo leaf extract 1,267 drugs
- Vinpocetine 209 drugs
- Siberian Rhodiola rosea 1,271 drugs
Other Ingredients (Inactive)
The capsule or tablet itself, fillers, coatings and flavors. Not part of the drug interaction check; the allergen check below reads them.
- Gelatin
- Magnesium Stearate
- Silica
- Microcrystalline Cellulose
- Permeate
Allergens in MPower
None of its ingredient names point to a major food allergen, and the label text we have carries no allergen statement.
Named on this label
- Gelatin (animal-derived)In the ingredients: Gelatin
Not named in the ingredients
- Milk
- Egg
- Fish
- Shellfish
- Tree nuts
- Peanuts
- Wheat or other gluten grains
- Soy
- Sesame
From the label text and ingredient names on file; we do not test products. With a serious allergy, check your bottle and ask the maker or your pharmacist.
What the Label Says
The maker’s own words, from the label. We do not verify or endorse them.
- FDA Statement of Identity
-
“Dietary Supplement”
- Directions
-
“Recommended Use: Dr. Burke (PhD) recommends 1 capsule in morning and 1 capsule in the afternoon for one week, then 2 capsules in morning and 2 capsules in the afternoon. On training days, take one serving 30-60 minutes before exercise. For best results use MPOWER every day and combine with diet & exercise.”
- General statements
-
“DECREASES BODY FAT BY 10.6%”
“Drug Delivery Technology”
11 more from the label
“Leave blank for exp. date and lot #”
“8x Greater Absorption & Effects”
“CLINICALLY TESTED”
“MPOWER is the world’s first dietary supplement designed to immediately stimulate mitochondrial biogenesis, a natural process that has been attributed to the exceptional leanness and endurance of the world’s greatest athletes. Mitochondria burn fat. MPOWER increases the number and size of mitochondria (mitochondrial biogenesis) inside muscle. This causes immediate energy and long lasting fat burning.*”
“MPOWER was clinically tested on athletes to confirm that it maintains normal physiological function (Safe) while improving performance (Effective). MPOWER contains no substance banned by national college sports associations, International Olympic Committee (IOC) or World Anti-Doping Agency (WADA).”
“NEW”
“OWN YOUR PERFORMANCE”
“powered by”
“THERMOGENESIS & ENERGY ACTIVATOR”
“THIS PRODUCT WILL NOT CAUSE AN ADVERSE ANALYTICAL FINDING AS DEFINED BY THE INTERNATIONAL OLYMPIC COMMITTEE (IOC) OR WORLD ANTI-DOPING AGENCY (WADA).”
“TRIGGERS INSTANT ENERGY THAT LASTS”
- Brand IP Statement(s)
-
“Certified SAEF(TM)(Safe and Effective First(TM))”
“PERMEATE(TM)”
- Seals and symbols
-
“Good Manufacturing Practices GMP NNfA”
“Made in USA”
“SAEF(TM)Safe And Effective First(TM)”
- Formulation
-
“DESIGNED FOR ATHLETES”
“MPOWER is used by male and female athletes during training, competition and recovery to immediately enhance fat loss, weight loss, perceived energy and endurance.*”
The MPower Label on File
The label scan on file at the NIH Dietary Supplement Label Database, dated February 2012. Always read the label on the bottle you have.
Product Facts
- Brand
- Rivalus
- Barcode (UPC)
- 807156000515
- Net contents
- 126 Sustained-Release Capsules
- Market status
- On market
- Date entered into DSLD
- Feb 23, 2012
- DSLD ID
- 5910
- Product type
- Other Combinations
- Supplement form
- Capsule
- Dietary claims / uses
- All Other, Structure/Function
- Intended target group(s)
- Adult (18 - 50 Years)
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
MPower by Rivalus Side Effects
Why this rating?
We look for three kinds of safety information on each ingredient: side effects reported in studies, a pregnancy and breastfeeding rating, and a safety write-up from our pharmacy team. Of the 13 ingredients we could check, twelve have side-effect reports, all 13 have a pregnancy rating and all 13 have a safety write-up.
So this rates how much is known, not whether MPower is right for you.
Reported with eight of its ingredients
- Most often
- Headache, nausea, trouble sleeping, dizziness, jitteriness and nervousness
- !Rare but serious
- Cancer, hyperglycemia and ketosis See details
HelloPharmacist Team Summary: MPower by Rivalus Side Effects
Caffeine in moderate doses is typically well tolerated, but this product combines caffeine from several sources, so you are most likely to notice jitteriness or nervousness, a racing or pounding heartbeat, and trouble sleeping.
- Upset stomach can also happen, and dizziness has been reported with some of its other ingredients, so see how it affects you before driving.
- Serious effects are rare but can happen with very high doses, and reported ones include stroke and allergic reactions, so if you have any serious reaction, call your doctor right away.
- Talk with your own doctor or pharmacist before starting if you have heart problems, high blood pressure, anxiety, a seizure disorder, or are pregnant, breastfeeding, or planning to give it to a child.
Side Effects, Ingredient by Ingredient
A supplement’s side effects come from its ingredients. Here is what is reported with each one.
Green Tea
Most reported
- Trouble sleeping or feeling jittery
- Nervousness or anxiety
- Upset stomach or nausea, especially on an empty stomach
- Headache
Guarana
Most reported
- Jitteriness
- Nervousness
- Fast or pounding heartbeat
- Trouble sleeping
Yerba Mate
Most reported
- Jitteriness
- Nervousness
- Fast heartbeat
- Headache
Caffeine
Most reported
- Feeling jittery, nervous, or anxious
- Racing or pounding heartbeat
- Trouble sleeping
- Upset stomach or heartburn
Red Raspberry
Most reported
- Nausea
- Loose stools
- Stomach upset
Ginkgo
Most reported
- Headache
- Upset stomach or nausea
- Dizziness
- Constipation or diarrhea
Vinpocetine
Most reported
- Stomach upset
- Nausea
- Headache
- Dizziness
Rhodiola
Most reported
- Dizziness
- Dry mouth
- Trouble sleeping (especially if taken later in the day)
- Jitteriness or feeling restless
MPower Warnings: Who Should Be Careful
MPower has twelve active ingredients, and each can carry warnings of its own. We checked the eight in our ingredient guides, and each warning below names the ingredient it comes from. Krebfuel, Campesterol and Conjugated Linoleic Acid and one more are not in our guides yet, so ask your pharmacist about them. If any of these apply to you, talk to your doctor or pharmacist before you start it.
- Green Tea3 warnings below
- Guarana3 warnings below
- Yerba Mate3 warnings below
- Caffeine2 warnings below
- Red Raspberry2 warnings below
- Ginkgo2 warnings below
- Vinpocetine2 warnings below
- Rhodiola3 warnings below
- KrebfuelNot in our guides yet
- CampesterolNot in our guides yet
- Conjugated Linoleic AcidNot in our guides yet
- EvodiamineNot in our guides yet
-
Bleeding Problems or Surgery
- Green TeaThe same goes for people with bleeding disorders or those preparing for surgery.
- Red RaspberryPeople with hormone-sensitive conditions, those who are scheduled for surgery, or anyone with a chronic health problem should speak with a pharmacist or doctor before using red raspberry supplements.
- VinpocetinePeople with bleeding disorders, those scheduled for surgery, people with low blood pressure, and anyone with a weakened immune system should be cautious because of possible effects on blood and immune cells.
- RhodiolaPeople with low blood pressure or those undergoing surgery should also talk to a healthcare provider first.
-
Blood Pressure
- GuaranaUse caution or avoid guarana if you have heart problems, high blood pressure, irregular heartbeat, anxiety, sleep problems, or are sensitive to caffeine.
- Yerba MateBecause it contains caffeine, people who are sensitive to stimulants, who have heart problems, high blood pressure, anxiety, or trouble sleeping should be cautious.
- CaffeineBe cautious if you: have heart problems, high blood pressure, an irregular heartbeat, anxiety, panic attacks, trouble sleeping, stomach ulcers, or seizure disorders.
-
Liver Disease
- Green TeaPeople with liver disease should be especially careful and check with a healthcare provider first.
-
Heart Conditions
- Green TeaBecause green tea contains caffeine, people who are sensitive to caffeine, have heart rhythm problems, anxiety, or trouble sleeping should be cautious.
-
Seizure Disorders
- GinkgoPeople with a history of seizures should be careful, as some reports suggest ginkgo could lower the seizure threshold, especially if a product is contaminated with ginkgo seeds.
-
Mental Health Conditions
- RhodiolaUse extra caution if you have a mental health condition such as bipolar disorder, since stimulating herbs could potentially affect mood.
-
Children
- GuaranaIt is not recommended for children and teens.
- Yerba MateChildren should generally avoid caffeinated mate.
- CaffeineChildren and teens should limit caffeine.
- GinkgoNever eat raw or roasted ginkgo seeds (nuts), which can be toxic, especially in children.
-
Other Cautions
- Yerba MateAlways talk to your pharmacist or doctor before using it regularly, especially if you have a medical condition.
- Red RaspberryStill, because high-quality safety studies are limited, caution is wise.
- RhodiolaChoose products from reputable brands, ideally with third-party testing, and always check with your pharmacist or doctor before starting.
-
What the Label Warns
- “KEEP OUT OF REACH OF CHILDREN”
- “Warning: Consult a physician before using if you are unaware of your current health status, if you are pregnant or nursing, if you have a medical condition, or if you or your family has a medical history of cardiovascular disease, diabetes, psychological disorders, hormonal abnormalities, or if you are taking any prescription drug. Do not use if you have high blood pressure, heart problems or are contemplating becoming pregnant. Discontinue use two weeks prior to surgery. Contains caffeine. Do not use in combination with other caffeinated products. Do not exceed maximum daily dosage.”
- “Do not use if safety seal is broken.”
- “For adult use only.”
The maker’s wording, from the product label.
-
Pregnant or Breastfeeding
Each ingredient’s rating for pregnancy and for breastfeeding, and what it covers.
Pregnancy
-
When the fruit is used orally in amounts commonly found in foods.
-
When red raspberry leaf is used orally and appropriately in medicinal amounts during late pregnancy under the supervision of a healthcare provider.
Red raspberry leaf is used by nurse midwives to facilitate delivery.
2 more points on this rating
- There is some evidence that red raspberry leaf in doses of up to 2.4 grams daily, beginning at 32 weeks' gestation and continued until delivery, can be safely used for this purpose.
- Make sure patients do not use red raspberry leaf without the guidance of a healthcare professional.
-
When red raspberry leaf is used orally in medicinal amounts throughout pregnancy or for self-treatment.
Red raspberry leaf might have estrogenic effects.
2 more points on this rating
- These effects can adversely affect pregnancy.
- Tell pregnant patients not to use red raspberry leaf at any time during pregnancy without the close supervision of a healthcare provider.
Breastfeeding
-
When the fruit is used orally in amounts commonly found in foods.
There is insufficient reliable information available about the safety of red raspberry leaf; avoid using.
Pregnancy
-
When used orally in moderate amounts.
Due to the caffeine content of green tea, pregnant patients should closely monitor their intake to ensure moderate consumption.
12 more points on this rating
- Fetal blood concentrations of caffeine approximate maternal concentrations.
- The use of caffeine during pregnancy is controversial; however, moderate consumption has not been associated with clinically important adverse fetal effects.
- In some studies consuming amounts over 200 mg daily is associated with a significantly increased risk of miscarriage.
- This increased risk may be most likely to occur in those with genotypes that confer a slow rate of caffeine metabolism.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, most healthy pregnant patients can safely consume doses up to 300 mg daily without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- Advise keeping caffeine consumption below 300 mg daily.
- This is similar to the amount of caffeine in about 6 cups of green tea.
- Keep in mind that only the amount of ADDED caffeine must be stated on product labels.
- The amount of caffeine found in ingredients such as green tea, which naturally contains caffeine, does not need to be provided.
- This can make it difficult to determine the total amount of caffeine in a given product.
- Based on animal models, green tea extract catechins are also transferred to the fetus, but in amounts 50-100 times less than maternal concentrations.
- The potential impact of these catechins on the human fetus is not known, but animal models suggest that the catechins are not teratogenic.
-
When used orally in amounts providing more than 300 mg caffeine daily.
Caffeine from green tea crosses the placenta, producing fetal blood concentrations similar to maternal levels.
16 more points on this rating
- Consumption of caffeine in amounts over 300 mg daily is associated with a significantly increased risk of miscarriage in some studies.
- Advise keeping caffeine consumption from all sources below 300 mg daily.
- This is similar to the amount of caffeine in about 6 cups of green tea.
- High maternal doses of caffeine throughout pregnancy have also resulted in symptoms of caffeine withdrawal in newborn infants.
- High doses of caffeine have also been associated with spontaneous abortion, premature delivery, and low birth weight.
- However, some research has also found that intrauterine exposure to even modest amounts of caffeine, based on maternal blood levels during the first trimester, is associated with a shorter stature in children ages 4-8 years.
- Keep in mind that only the amount of ADDED caffeine must be stated on product labels.
- The amount of caffeine found in ingredients such as green tea, which naturally contains caffeine, does not need to be provided.
- This can make it difficult to determine the total amount of caffeine in a given product.
- There is also concern that consuming large amounts of green tea might have antifolate activity and potentially increase the risk of folic acid deficiency-related birth defects.
- Catechins in green tea inhibit the enzyme dihydrofolate reductase in vitro.
- This enzyme is responsible for converting folic acid to its active form.
- Preliminary evidence suggests that increasing maternal green tea consumption is associated with increased risk of spina bifida.
- Also, evidence from epidemiological research suggests that serum folate levels in pregnant patients with high green tea intake (57.3 mL per 1000 kcal) are decreased compared to participants who consume moderate or low amounts of green tea.
- More evidence is needed to determine the safety of using green tea during pregnancy.
- For now, advise pregnant patients to avoid consuming large quantities of green tea.
Breastfeeding
-
When used orally in moderate amounts.
Due to the caffeine content of green tea, nursing parents should closely monitor caffeine intake.
Breast milk concentrations of caffeine are thought to be approximately 50% of maternal serum concentrations.
-
When used orally in large amounts.
Consumption of green tea might cause irritability and increased bowel activity in nursing infants.
There is insufficient reliable information available about the safety of green tea extracts when applied topically during breast-feeding.
Show 6 more ingredients
Pregnancy
-
When consumed in amounts commonly found in foods.
Due to the caffeine content of guarana, intake should be closely monitored during pregnancy to ensure moderate consumption.
7 more points on this rating
- Although it is not considered a teratogen, caffeine crosses the placenta and causes dose-dependent increases in fetal blood concentrations.
- The use of caffeine during pregnancy is controversial; however, moderate consumption has not been associated with clinically important adverse fetal effects.
- In some studies, consuming amounts over 200 mg daily is associated with a significantly increased risk of miscarriage.
- This increased risk may be most likely to occur in individuals with genotypes that confer a slow rate of caffeine metabolism.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, caffeine can be safely consumed in doses up to 300 mg daily without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- However, some research has also found that intrauterine exposure to even modest amounts of caffeine, based on maternal blood levels during the first trimester, is associated with a shorter stature in children ages 4-8 years.
- Advise individuals to keep caffeine consumption below 300 mg daily during pregnancy.
-
When used orally in amounts over 300 mg daily.
Although it is not considered a teratogen, caffeine crosses the placenta and causes dose-dependent increases in fetal blood concentrations.
4 more points on this rating
- Consumption of caffeine in amounts over 300 mg daily is associated with a significantly increased risk of miscarriage in some studies.
- Advise keeping caffeine consumption from all sources below 300 mg daily.
- High maternal doses of caffeine throughout pregnancy have resulted in symptoms of caffeine withdrawal in newborn infants.
- High doses of caffeine have also been associated with spontaneous abortion, premature delivery, and low birth weight.
Breastfeeding
-
When used orally in amounts commonly found in foods.
Due to the caffeine content of guarana, intake should be closely monitored when breast-feeding.
Breast milk concentrations of caffeine are thought to be approximately 50% of serum concentrations.
-
When used orally in large amounts.
Consumption of guarana might cause irritability and increased bowel activity in nursing infants.
Large doses or excessive intake of guarana should be avoided when breast-feeding.
Pregnancy
-
When used orally.
Yerba mate is associated with an increased risk of cancer, including esophageal, kidney, bladder, cervical, prostate, lung, renal cell, and possibly mouth and laryngeal cancer.
9 more points on this rating
- However, teratogenic studies have not been performed.
- Yerba mate also contains caffeine.
- Caffeine crosses the placenta, producing fetal blood concentrations similar to parental levels.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, most healthy pregnant patients can safely consume caffeine in doses up to 300 mg daily without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- It is generally recommended to avoid consuming more than 300 mg of caffeine daily, or around 6-7 cups of yerba mate daily, when pregnant.
- High doses of caffeine throughout pregnancy have resulted in symptoms of caffeine withdrawal in newborn infants.
- Caffeine in doses of greater than 300 mg daily has also been associated with spontaneous abortion, premature delivery, and low birth weight, although one retrospective study found that consuming yerba mate tea during pregnancy was not associated with preterm or small for gestational age births.
- However, this study did not consider the amount of yerba mate or caffeine consumed, only the frequency of consumption.
- Some research has found that intrauterine exposure to even modest amounts of caffeine, based on maternal blood levels during the first trimester, is associated with a shorter stature in children ages 4-8 years.
Breastfeeding
-
When used orally.
Yerba mate is associated with an increased risk of cancer, including esophageal, kidney, bladder, cervical, prostate, lung, renal cell, and possibly mouth and laryngeal cancer.
3 more points on this rating
- Whether carcinogenic constituents of yerba mate are transferred via breast milk is unknown.
- Yerba mate contains caffeine.
- Consumption of yerba mate might cause irritability and increased bowel activity in nursing infants.
Pregnancy
-
When used orally in amounts commonly found in foods.
Intakes of caffeine should be monitored during pregnancy.
10 more points on this rating
- Caffeine crosses the human placenta, but is not considered a teratogen.
- Fetal blood and tissue levels are similar to maternal concentrations.
- The use of caffeine during pregnancy is controversial; however, moderate consumption has not been associated with clinically important adverse fetal effects.
- In some studies consuming amounts over 200 mg daily is associated with a significantly increased risk of miscarriage.
- This increased risk seems to occur in those with genotypes that confer a slow rate of caffeine metabolism.
- According to a review by Health Canada, and a subsequent large meta-analysis conducted in the US, up to 300 mg daily can be consumed during pregnancy without an increased risk of spontaneous abortion, stillbirth, preterm birth, fetal growth retardation, or congenital malformations.
- However, observational research in a Norwegian cohort found that caffeine consumption is associated with a 16% increased odds of the baby being born small for gestational age when compared with no consumption.
- The same Norwegian cohort found that low to moderate caffeine consumption during pregnancy is not associated with changes in neurodevelopment in children up to 8 years of age.
- Advise patients to keep caffeine consumption below 300 mg daily during pregnancy.
- This is similar to the amount of caffeine in about 3 cups of coffee or tea.
-
When used orally in amounts over 300 mg daily.
Caffeine crosses the placenta, producing fetal blood concentrations similar to maternal levels.
8 more points on this rating
- Consumption of caffeine in amounts over 300 mg daily is associated with a significantly increased risk of miscarriage in some studies.
- Advise patients to keep caffeine consumption below 300 mg daily during pregnancy.
- This is similar to the amount of caffeine in about 3 cups of coffee or tea.
- Additionally, high doses of caffeine throughout pregnancy have resulted in symptoms of caffeine withdrawal in newborn infants.
- High doses of caffeine have also been associated with spontaneous abortion, premature delivery, and low birth weight.
- In a cohort of mother/infant pairs with a median maternal plasma caffeine level of 168.5 ng/mL (range 29.5-650.5 ng/mL) during pregnancy, birth weights and lengths were lower in the 4th quartile of caffeine intake compared with the 1st.
- By age 7, heights and weights were lower by 1.5 cm and 1.1 kg respectively.
- In another cohort of mother/infant pairs with higher maternal pregnancy plasma caffeine levels, median 625.5 ng/mL (range 86.2 to 1994.7 ng/mL), heights at age 8 were 2.2 cm lower, but there was no difference in weights.
Breastfeeding
-
When used orally in amounts commonly found in foods.
Caffeine intake should be closely monitored while breast-feeding.
During lactation, breast milk concentrations of caffeine are thought to be approximately 50% of serum concentrations and caffeine peaks in breastmilk approximately 1-2 hours after consumption.
-
When used orally in large amounts.
Caffeine is excreted slowly in infants and may accumulate.
Caffeine can cause sleep disturbances, irritability, and increased bowel activity in breast-fed infants exposed to caffeine.
Pregnancy
-
When used orally.
There is concern that ginkgo might have labor-inducing and hormonal effects.
2 more points on this rating
- There is also concern that the antiplatelet effects of ginkgo could prolong bleeding time if taken around the time of labor and delivery.
- Theoretically, ginkgo might adversely affect pregnancy outcome; avoid using during pregnancy.
Breastfeeding
-
Insufficient reliable information available; avoid using.
Pregnancy
-
When used orally.
In June 2019, the US Food and Drug Administration (FDA) issued a statement of warning that those who are pregnant or who could become pregnant should avoid vinpocetine.
2 more points on this rating
- In rats, vinpocetine has been associated with an increased risk of miscarriage at a dose of 60 mg/kg daily and with reduced fetal weight and increased incidence of birth defects at a dose of 5-20 mg/kg.
- Based on pharmacokinetic analyses, a daily vinpocetine dose of 10 mg in humans is comparable to a daily dose of 5 mg/kg in rats.
Breastfeeding
-
Insufficient reliable information available; avoid using.
Pregnancy and Breastfeeding The record rates both the same
-
Insufficient reliable information available; avoid using.
Our pharmacy team’s notes
- Vinpocetine and ginkgo are both rated Possibly Unsafe in pregnancy, and they are best avoided.
Ratings and the words beside them are from the Natural Medicines database, which we license.
-
Rare but Serious Side Effects
-
!
Green Tea
A rare but serious concern with concentrated green tea extract supplements is liver damage.
Orally: Hepatotoxicity, hypokalemia, and thrombotic thrombocytopenic purpura have been reported rarely.
-
!
Guarana
Very large amounts of caffeine — especially from concentrated supplements or energy products combined with other stimulants — can be dangerous and, in rare cases, lead to serious heart problems.
-
!
Yerba Mate
Orally: Cancer, hyperglycemia, ketosis, metabolic acidosis, sinus tachycardia. These adverse effects are more common with high doses or long-term use.
-
!
Caffeine
Serious effects are rare but can happen with very high doses.
Caffeine is generally well tolerated in moderate amounts for healthy adults, but high doses can cause serious side effects, and small amounts pass into breast milk.
Orally: Stroke has been reported rarely.
-
!
Red Raspberry
Allergic reactions are possible but uncommon.
-
!
Ginkgo
More serious but rare concerns include increased bleeding or bruising.
Orally: Arrhythmia, bleeding, Stevens-Johnson syndrome.
-
!
Vinpocetine
Orally: Agranulocytosis, arrhythmias, and seizures.
-
!
Our pharmacy team on MPower
Green tea extract has been linked to rare liver injury at concentrated doses, and ginkgo may increase bleeding risk.
When to get help: a serious allergic reaction, with trouble breathing or swelling of the face, lips or throat, needs emergency care: call 911. For any other side effect that worries you, call your doctor or pharmacist.
These reports describe each ingredient, not studies of this exact product. Not medical advice: a side effect you notice after starting a supplement is worth a word with your pharmacist or doctor.
MPower by Rivalus Drug Interactions
We checked all twelve active ingredients in this supplement against every drug in our records. A drug can interact with it through any one of them. Four of them are not in our interaction records yet.
A major interaction on record
3 of 3, on a scale from Minor or none to Major.Why this rating?
We rate this by the most serious interaction on record, not by how many there are. For Vinpocetine, Red Raspberry, Ginkgo, Yerba Mate and Rhodiola, the most serious is rated major, which means the combination is best avoided, or used only under close supervision. Some involve kinds of drugs where a small change can matter, such as blood thinners, seizure drugs and transplant drugs.
1,683 drugs are on the full list. What matters is whether one you take is on it, so check yours with the interaction checker on this page.
Eight of its twelve active ingredients have drug interactions on record. The ones below matter most. We have no interaction records for Krebfuel, Campesterol, Conjugated Linoleic Acid and Evodiamine.
- Interacts with
- 1,267 drugs
- Most serious
- Major
- Ginkgo can also raise blood levels of talinolol, which is also rated Major.
- Interacts with
- 1,294 drugs
- Most serious
- Major
- Most of its records involve Cytochrome P450 3A4 (CYP3A4) Substrates, Hepatotoxic Drugs and P-glycoprotein Substrates.
- Interacts with
- 1,271 drugs
- Most serious
- Moderate
- Most of its records involve Cytochrome P450 3A4 (CYP3A4) Substrates, CNS Depressants and P-glycoprotein Substrates.
Show three more ingredients
- Interacts with
- 1,087 drugs
- Most serious
- Major
- Most of its records involve Cytochrome P450 3A4 (CYP3A4) Substrates, Stimulant Drugs and Anticoagulant/Antiplatelet Drugs.
- Interacts with
- 655 drugs
- Most serious
- Major
- Most of its records involve Stimulant Drugs, Anticoagulant/Antiplatelet Drugs and Cytochrome P450 1A2 (CYP1A2) Inhibitors.
- Interacts with
- 655 drugs
- Most serious
- Major
- Most of its records involve Stimulant Drugs, Anticoagulant/Antiplatelet Drugs and Cytochrome P450 1A2 (CYP1A2) Inhibitors.
And two more ingredients with records, each in the cards below.
From the HelloPharmacist Team
Looking at the supplement as a whole rather than one ingredient at a time:
- MPower by Rivalus can interact with several medications through its caffeine, vinpocetine, malic acid, Siberian rhodiola, green tea, guarana, yerba mate, red raspberry, and ginkgo content.
- The most serious interaction is rated Major: caffeine, along with the caffeine in green tea, guarana, and yerba mate, can raise the risk of stimulant side effects when combined with ephedrine.
- There is evidence this combination may increase the risk of serious effects such as high blood pressure, heart attack, stroke, seizures, and death.
Summarized by the HelloPharmacist pharmacy team from the interaction records below. How it is written How we use AI
Why MPower Interacts, Ingredient by Ingredient
A product interacts through its ingredients. Each card: how many drugs, the most serious rating, and the kinds of drugs it affects most (tap a kind for what it means).
The ingredients driving the most interactions
-
Green Tea extract 1,294 drugs
Most serious: Major58 interaction records on file
The kinds of drugs it affects most
- 645 drugs
- 372 drugs
- 202 drugs
- 172 drugs
Every Green Tea drug interaction, 58 records The Green Tea records cite 219 references, listed in the Green Tea guide.
-
Siberian Rhodiola rosea 1,271 drugs
Most serious: Moderate10 interaction records on file
The kinds of drugs it affects most
- 645 drugs
- 248 drugs
- 202 drugs
- 186 drugs
Every Rhodiola drug interaction, 10 records The Rhodiola records cite 13 references, listed in the Rhodiola guide.
-
Ginkgo leaf extract 1,267 drugs
Most serious: Major23 interaction records on file
The kinds of drugs it affects most
- 645 drugs
- 418 drugs
- 202 drugs
- 186 drugs
Every Ginkgo drug interaction, 23 records The Ginkgo records cite 97 references, listed in the Ginkgo guide.
-
Yerba Mate 1,087 drugs
Most serious: Major43 interaction records on file
The kinds of drugs it affects most
- 645 drugs
- 172 drugs
- 122 drugs
- 90 drugs
Every Yerba Mate drug interaction, 43 records The Yerba Mate records cite 124 references, listed in the Yerba Mate guide.
-
Guarana 655 drugs
Most serious: Major41 interaction records on file
The kinds of drugs it affects most
- 172 drugs
- 122 drugs
- 90 drugs
- 86 drugs
Every Guarana drug interaction, 41 records The Guarana records cite 115 references, listed in the Guarana guide.
-
Caffeine Anhydrous 655 drugs
Most serious: Major41 interaction records on file
The kinds of drugs it affects most
- 172 drugs
- 122 drugs
- 90 drugs
- 86 drugs
Every Caffeine drug interaction, 41 records The Caffeine records cite 235 references, listed in the Caffeine guide.
-
Vinpocetine 209 drugs
Most serious: Moderate3 interaction records on file
The kinds of drugs it affects most
- 122 drugs
- 112 drugs
- 2 drugs
Every Vinpocetine drug interaction, 3 records The Vinpocetine records cite 27 references, listed in the Vinpocetine guide.
-
Rheosmin/Raspberry Ketone 135 drugs
Most serious: Moderate2 interaction records on file
The kinds of drugs it affects most
- 122 drugs
- 13 drugs
Every Red Raspberry drug interaction, 2 records The Red Raspberry records cite 8 references, listed in the Red Raspberry guide.
The Breakdown by Severity
Each drug counted once, at its most serious rating. Tap a tile to list those drugs.
Find Your Drug
Type a drug or brand name to see whether it is on the list.
- Only drugs with a documented interaction are listed, the most serious first.
- A drug with no known interaction is not listed, but searching its name tells you so.
- Open a drug to see which ingredient is responsible. Of those, 1,197 are single drugs and 485 are combination products (two or more drugs in one), each listed under its own name.
-
Peginterferon Alfa-2bPeg-Intron, ViraferonPeg Moderate
The ingredient responsible:
-
Green Tea Extract Moderate Peginterferon Alfa-2b is in the Hepatotoxic Drugs category.
Theoretically, concomitant use might have additive adverse hepatotoxic effects.
The full Green Tea Extract + Peginterferon Alfa-2b interaction
-
-
RilpivirineEdurant, Edurant Ped Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Rilpivirine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Rilpivirine interaction -
Green Tea Extract Moderate Rilpivirine is in these Hepatotoxic Drugs, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, concomitant use might have additive adverse hepatotoxic effects.
The full Green Tea Extract + Rilpivirine interaction -
Yerba Mate Minor Rilpivirine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Rilpivirine interaction -
Siberian Rhodiola Rosea Minor Rilpivirine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP3A4.
The full Siberian Rhodiola Rosea + Rilpivirine interaction
-
-
PyrazinamideTebrazid Moderate
The ingredient responsible:
-
Green Tea Extract Moderate Pyrazinamide is in the Hepatotoxic Drugs category.
Theoretically, concomitant use might have additive adverse hepatotoxic effects.
The full Green Tea Extract + Pyrazinamide interaction
-
-
PargylineEutonyl Moderate
The 2 ingredients responsible:
-
Malate Moderate Pargyline is in the Antihypertensive Drugs category.
Theoretically, malic acid might increase the risk of hypotension when taken with antihypertensive drugs.
The full Malate + Pargyline interaction -
Siberian Rhodiola Rosea Moderate Pargyline is in the Antihypertensive Drugs category.
Theoretically, taking rhodiola with antihypertensive drugs might increase the risk of hypotension.
The full Siberian Rhodiola Rosea + Pargyline interaction
-
-
GatifloxacinTequin, Tequin Injection Moderate
The 4 ingredients responsible:
-
Yerba Mate Moderate Gatifloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of the caffeine in yerba mate.
The full Yerba Mate + Gatifloxacin interaction -
Caffeine Anhydrous Moderate Gatifloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Caffeine Anhydrous + Gatifloxacin interaction -
Green Tea Extract Moderate Gatifloxacin is in these Quinolone Antibiotics, Organic Anion-transporting Polypeptide Substrates (OATP), Hepatotoxic Drugs categories.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Green Tea Extract + Gatifloxacin interaction -
Guarana Minor Gatifloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Guarana + Gatifloxacin interaction
-
-
Fluorouracil (iv)Fluorouracil Moderate
The 2 ingredients responsible:
-
Green Tea Extract Moderate Fluorouracil (iv) is in the 5-Fluorouracil category.
Theoretically, high doses of green tea might increase the effects and side effects of 5-fluorouracil.
The full Green Tea Extract + Fluorouracil (iv) interaction -
Siberian Rhodiola Rosea Moderate Fluorouracil (iv) is in the Immunosuppressants category.
Theoretically, rhodiola use might interfere with immunosuppressive therapy.
The full Siberian Rhodiola Rosea + Fluorouracil (iv) interaction
-
-
SibutramineMeridia Moderate
The 6 ingredients responsible:
-
Yerba Mate Moderate Sibutramine is in these Cytochrome P450 3A4 (CYP3A4) Substrates, Stimulant Drugs categories.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Sibutramine interaction -
Ginkgo Leaf Extract Moderate Sibutramine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Sibutramine interaction -
Guarana Moderate Sibutramine is in the Stimulant Drugs category.
Theoretically, concomitant use might increase stimulant adverse effects.
The full Guarana + Sibutramine interaction -
Green Tea Extract Moderate Sibutramine is in these Stimulant Drugs, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, concomitant use might increase stimulant adverse effects.
The full Green Tea Extract + Sibutramine interaction -
Caffeine Anhydrous Moderate Sibutramine is in the Stimulant Drugs category.
Theoretically, concomitant use might increase stimulant adverse effects.
The full Caffeine Anhydrous + Sibutramine interaction -
Siberian Rhodiola Rosea Minor Sibutramine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP3A4.
The full Siberian Rhodiola Rosea + Sibutramine interaction
-
-
ElotuzumabEmpliciti Moderate
The ingredient responsible:
-
Green Tea Extract Moderate Elotuzumab is in the Hepatotoxic Drugs category.
Theoretically, concomitant use might have additive adverse hepatotoxic effects.
The full Green Tea Extract + Elotuzumab interaction
-
-
Olipudase Alfa-rpcpXenpozyme Moderate
The ingredient responsible:
-
Green Tea Extract Moderate Olipudase Alfa-rpcp is in the Hepatotoxic Drugs category.
Theoretically, concomitant use might have additive adverse hepatotoxic effects.
The full Green Tea Extract + Olipudase Alfa-rpcp interaction
-
-
IothalamateConray Moderate
The ingredient responsible:
-
Ginkgo Leaf Extract Moderate Iothalamate is in the Seizure Threshold Lowering Drugs category.
Theoretically, taking ginkgo with drugs that lower the seizure threshold might increase the risk for convulsions.
The full Ginkgo Leaf Extract + Iothalamate interaction
-
-
TasimelteonHetlioz, Hetlioz Lq Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Tasimelteon is in these Cytochrome P450 1A2 (CYP1A2) Substrates, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, ginkgo might increase levels of drugs metabolized by CYP1A2.
The full Ginkgo Leaf Extract + Tasimelteon interaction -
Green Tea Extract Minor Tasimelteon is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea Extract + Tasimelteon interaction -
Siberian Rhodiola Rosea Minor Tasimelteon is in these CNS Depressants, Cytochrome P450 3A4 (CYP3A4) Substrates, Cytochrome P450 1A2 (CYP1A2) Substrates categories.
Theoretically, rhodiola might increase the risk of adverse effects when taken with CNS depressants.
The full Siberian Rhodiola Rosea + Tasimelteon interaction -
Yerba Mate Minor Tasimelteon is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Tasimelteon interaction
-
-
Pimavanserin TartrateNuplazid Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Pimavanserin Tartrate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Pimavanserin Tartrate interaction -
Yerba Mate Minor Pimavanserin Tartrate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Pimavanserin Tartrate interaction -
Siberian Rhodiola Rosea Minor Pimavanserin Tartrate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP3A4.
The full Siberian Rhodiola Rosea + Pimavanserin Tartrate interaction -
Green Tea Extract Minor Pimavanserin Tartrate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea Extract + Pimavanserin Tartrate interaction
-
-
VibegronGemtesa Moderate
The 6 ingredients responsible:
-
Green Tea Extract Moderate Vibegron is in these P-glycoprotein Substrates, Beta-adrenergic Agonists, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Green tea might increase the levels and adverse effects of P-glycoprotein (P-gp) substrates.
The full Green Tea Extract + Vibegron interaction -
Caffeine Anhydrous Moderate Vibegron is in the Beta-adrenergic Agonists category.
Theoretically, large amounts of caffeine might increase the cardiac inotropic effects of beta-agonists.
The full Caffeine Anhydrous + Vibegron interaction -
Guarana Moderate Vibegron is in the Beta-adrenergic Agonists category.
Theoretically, concomitant use might increase the clinical effects of beta-adrenergic agonists.
The full Guarana + Vibegron interaction -
Siberian Rhodiola Rosea Moderate Vibegron is in these Cytochrome P450 3A4 (CYP3A4) Substrates, P-glycoprotein Substrates categories.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP3A4.
The full Siberian Rhodiola Rosea + Vibegron interaction -
Yerba Mate Moderate Vibegron is in these Beta-adrenergic Agonists, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, the caffeine in yerba mate might increase the cardiac inotropic effects of beta-agonists, especially if taken in large amounts.
The full Yerba Mate + Vibegron interaction -
Ginkgo Leaf Extract Moderate Vibegron is in these P-glycoprotein Substrates, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, taking ginkgo with P-glycoprotein substrates might increase the levels and adverse effects of these substrates.
The full Ginkgo Leaf Extract + Vibegron interaction
-
-
Cerivastatin SodiumBaycol Moderate
The ingredient responsible:
-
Green Tea Extract Moderate Cerivastatin Sodium is in these Organic Anion-transporting Polypeptide Substrates (OATP), Hepatotoxic Drugs categories.
Theoretically, green tea might reduce the absorption of organic anion-transporting polypeptide (OATP) substrates.
The full Green Tea Extract + Cerivastatin Sodium interaction
-
-
SparfloxacinZagam Moderate
The 6 ingredients responsible:
-
Green Tea Extract Moderate Sparfloxacin is in these Hepatotoxic Drugs, P-glycoprotein Substrates, Quinolone Antibiotics and 1 more categories.
Theoretically, concomitant use might have additive adverse hepatotoxic effects.
The full Green Tea Extract + Sparfloxacin interaction -
Siberian Rhodiola Rosea Moderate Sparfloxacin is in the P-glycoprotein Substrates category.
Theoretically, rhodiola might increase levels of P-glycoprotein substrates.
The full Siberian Rhodiola Rosea + Sparfloxacin interaction -
Yerba Mate Moderate Sparfloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of the caffeine in yerba mate.
The full Yerba Mate + Sparfloxacin interaction -
Ginkgo Leaf Extract Moderate Sparfloxacin is in the P-glycoprotein Substrates category.
Theoretically, taking ginkgo with P-glycoprotein substrates might increase the levels and adverse effects of these substrates.
The full Ginkgo Leaf Extract + Sparfloxacin interaction -
Caffeine Anhydrous Moderate Sparfloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Caffeine Anhydrous + Sparfloxacin interaction -
Guarana Minor Sparfloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Guarana + Sparfloxacin interaction
-
-
Adenosine (prescription Drug)Adenocard, Adenocor, Adenoscan Moderate
The 4 ingredients responsible:
-
Guarana Moderate
Theoretically, guarana might decrease the vasodilatory effects of adenosine and interfere with its use prior to stress testing.
The full Guarana + Adenosine (prescription Drug) interaction -
Green Tea Extract Moderate
Theoretically, green tea might decrease the vasodilatory effects of adenosine and interfere with its use prior to stress testing.
The full Green Tea Extract + Adenosine (prescription Drug) interaction -
Caffeine Anhydrous Moderate
Theoretically, caffeine might decrease the vasodilatory effects of adenosine and interfere with its use prior to stress testing.
The full Caffeine Anhydrous + Adenosine (prescription Drug) interaction -
Yerba Mate Moderate
Theoretically, the caffeine in yerba mate might decrease the vasodilatory effects of adenosine and interfere with its use prior to stress testing.
The full Yerba Mate + Adenosine (prescription Drug) interaction
-
-
EfalizumabRaptiva Moderate
The ingredient responsible:
-
Siberian Rhodiola Rosea Moderate Efalizumab is in the Immunosuppressants category.
Theoretically, rhodiola use might interfere with immunosuppressive therapy.
The full Siberian Rhodiola Rosea + Efalizumab interaction
-
-
Lefamulin AcetateXenleta Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Lefamulin Acetate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Lefamulin Acetate interaction -
Yerba Mate Minor Lefamulin Acetate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Lefamulin Acetate interaction -
Green Tea Extract Minor Lefamulin Acetate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea Extract + Lefamulin Acetate interaction -
Siberian Rhodiola Rosea Minor Lefamulin Acetate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP3A4.
The full Siberian Rhodiola Rosea + Lefamulin Acetate interaction
-
-
ClinafloxacinClinafloxacin Moderate
The 5 ingredients responsible:
-
Green Tea Extract Moderate Clinafloxacin is in these Quinolone Antibiotics, Organic Anion-transporting Polypeptide Substrates (OATP) categories.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Green Tea Extract + Clinafloxacin interaction -
Caffeine Anhydrous Moderate Clinafloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Caffeine Anhydrous + Clinafloxacin interaction -
Yerba Mate Moderate Clinafloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of the caffeine in yerba mate.
The full Yerba Mate + Clinafloxacin interaction -
Ginkgo Leaf Extract Moderate Clinafloxacin is in the Seizure Threshold Lowering Drugs category.
Theoretically, taking ginkgo with drugs that lower the seizure threshold might increase the risk for convulsions.
The full Ginkgo Leaf Extract + Clinafloxacin interaction -
Guarana Minor Clinafloxacin is in the Quinolone Antibiotics category.
Theoretically, quinolone antibiotics might increase the levels and adverse effects of caffeine.
The full Guarana + Clinafloxacin interaction
-
-
VincristineVincasar Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Vincristine is in these P-glycoprotein Substrates, Cytochrome P450 3A4 (CYP3A4) Substrates, Seizure Threshold Lowering Drugs categories.
Theoretically, taking ginkgo with P-glycoprotein substrates might increase the levels and adverse effects of these substrates.
The full Ginkgo Leaf Extract + Vincristine interaction -
Green Tea Extract Moderate Vincristine is in these P-glycoprotein Substrates, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Green tea might increase the levels and adverse effects of P-glycoprotein (P-gp) substrates.
The full Green Tea Extract + Vincristine interaction -
Siberian Rhodiola Rosea Moderate Vincristine is in these P-glycoprotein Substrates, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, rhodiola might increase levels of P-glycoprotein substrates.
The full Siberian Rhodiola Rosea + Vincristine interaction -
Yerba Mate Minor Vincristine is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Vincristine interaction
-
-
PhenylpropanolamineDexatrim, Just-One-Per-Day, Mini Slims, Mini Thin Diet Aid, Phenylpropanolamine and 3 more Moderate
The 4 ingredients responsible:
-
Yerba Mate Moderate Phenylpropanolamine is in the Stimulant Drugs category.
Theoretically, concomitant use of stimulant drugs and yerba mate might increase stimulant adverse effects.
The full Yerba Mate + Phenylpropanolamine interaction -
Guarana Moderate Phenylpropanolamine is in the Stimulant Drugs category.
Theoretically, concomitant use might increase stimulant adverse effects.
The full Guarana + Phenylpropanolamine interaction -
Green Tea Extract Moderate Phenylpropanolamine is in the Stimulant Drugs category.
Theoretically, concomitant use might increase stimulant adverse effects.
The full Green Tea Extract + Phenylpropanolamine interaction -
Caffeine Anhydrous Moderate Phenylpropanolamine is in the Stimulant Drugs category.
Theoretically, concomitant use might increase stimulant adverse effects.
The full Caffeine Anhydrous + Phenylpropanolamine interaction
-
-
ApremilastOtezla Moderate
The 4 ingredients responsible:
-
Siberian Rhodiola Rosea Moderate Apremilast is in these P-glycoprotein Substrates, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, rhodiola might increase levels of P-glycoprotein substrates.
The full Siberian Rhodiola Rosea + Apremilast interaction -
Ginkgo Leaf Extract Moderate Apremilast is in these Cytochrome P450 3A4 (CYP3A4) Substrates, P-glycoprotein Substrates categories.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Apremilast interaction -
Green Tea Extract Moderate Apremilast is in these Cytochrome P450 3A4 (CYP3A4) Substrates, P-glycoprotein Substrates categories.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea Extract + Apremilast interaction -
Yerba Mate Minor Apremilast is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Apremilast interaction
-
-
DeserpidineHarmonyl Moderate
The 2 ingredients responsible:
-
Malate Moderate Deserpidine is in the Antihypertensive Drugs category.
Theoretically, malic acid might increase the risk of hypotension when taken with antihypertensive drugs.
The full Malate + Deserpidine interaction -
Siberian Rhodiola Rosea Moderate Deserpidine is in the Antihypertensive Drugs category.
Theoretically, taking rhodiola with antihypertensive drugs might increase the risk of hypotension.
The full Siberian Rhodiola Rosea + Deserpidine interaction
-
-
Pexidartinib HydrochlorideTuralio Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Pexidartinib Hydrochloride is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Pexidartinib Hydrochloride interaction -
Green Tea Extract Moderate Pexidartinib Hydrochloride is in these Hepatotoxic Drugs, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, concomitant use might have additive adverse hepatotoxic effects.
The full Green Tea Extract + Pexidartinib Hydrochloride interaction -
Yerba Mate Minor Pexidartinib Hydrochloride is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Pexidartinib Hydrochloride interaction -
Siberian Rhodiola Rosea Minor Pexidartinib Hydrochloride is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP3A4.
The full Siberian Rhodiola Rosea + Pexidartinib Hydrochloride interaction
-
-
Bupivacaine HciXaracoll Moderate
The ingredient responsible:
-
Ginkgo Leaf Extract Moderate Bupivacaine Hci is in the Seizure Threshold Lowering Drugs category.
Theoretically, taking ginkgo with drugs that lower the seizure threshold might increase the risk for convulsions.
The full Ginkgo Leaf Extract + Bupivacaine Hci interaction
-
-
EflornithineOmidyl, Vaniqa Moderate
The ingredient responsible:
-
Ginkgo Leaf Extract Moderate Eflornithine is in the Seizure Threshold Lowering Drugs category.
Theoretically, taking ginkgo with drugs that lower the seizure threshold might increase the risk for convulsions.
The full Ginkgo Leaf Extract + Eflornithine interaction
-
-
Fesoterodine FumarateToviaz Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Fesoterodine Fumarate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Fesoterodine Fumarate interaction -
Siberian Rhodiola Rosea Minor Fesoterodine Fumarate is in these CNS Depressants, Cytochrome P450 3A4 (CYP3A4) Substrates categories.
Theoretically, rhodiola might increase the risk of adverse effects when taken with CNS depressants.
The full Siberian Rhodiola Rosea + Fesoterodine Fumarate interaction -
Yerba Mate Minor Fesoterodine Fumarate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Fesoterodine Fumarate interaction -
Green Tea Extract Minor Fesoterodine Fumarate is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea Extract + Fesoterodine Fumarate interaction
-
-
ButorphanolStadol Moderate
The 2 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Butorphanol is in the Seizure Threshold Lowering Drugs category.
Theoretically, taking ginkgo with drugs that lower the seizure threshold might increase the risk for convulsions.
The full Ginkgo Leaf Extract + Butorphanol interaction -
Siberian Rhodiola Rosea Minor Butorphanol is in the CNS Depressants category.
Theoretically, rhodiola might increase the risk of adverse effects when taken with CNS depressants.
The full Siberian Rhodiola Rosea + Butorphanol interaction
-
-
Simeprevir SodiumOlysio Moderate
The 4 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Simeprevir Sodium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, ginkgo might decrease levels of drugs metabolized by CYP3A4.
The full Ginkgo Leaf Extract + Simeprevir Sodium interaction -
Siberian Rhodiola Rosea Minor Simeprevir Sodium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP3A4.
The full Siberian Rhodiola Rosea + Simeprevir Sodium interaction -
Green Tea Extract Minor Simeprevir Sodium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Green tea is unlikely to produce clinically significant changes in the levels and clinical effects of CYP3A4 substrates.
The full Green Tea Extract + Simeprevir Sodium interaction -
Yerba Mate Minor Simeprevir Sodium is in the Cytochrome P450 3A4 (CYP3A4) Substrates category.
Theoretically, yerba mate might increase the levels and clinical effects of CYP3A4 substrates.
The full Yerba Mate + Simeprevir Sodium interaction
-
-
RopivacaineNaropin Moderate
The 2 ingredients responsible:
-
Ginkgo Leaf Extract Moderate Ropivacaine is in the Cytochrome P450 1A2 (CYP1A2) Substrates category.
Theoretically, ginkgo might increase levels of drugs metabolized by CYP1A2.
The full Ginkgo Leaf Extract + Ropivacaine interaction -
Siberian Rhodiola Rosea Minor Ropivacaine is in the Cytochrome P450 1A2 (CYP1A2) Substrates category.
Theoretically, rhodiola might increase levels of drugs metabolized by CYP1A2.
The full Siberian Rhodiola Rosea + Ropivacaine interaction
-
Does It Work? MPower by Rivalus
How it rates in the research so far, then each ingredient on its own. A grade is the research so far, never an endorsement.
What It Is Marketed For
Body fat reduction and athletic performance
From the claims on the product’s label.
Closest match for what it is marketed for
Caffeine for athletic performance
Good studies support it.
Our pharmacy team’s notes on this supplement
- Several other ingredients, including rhodiola, guarana, yerba mate, and red raspberry, are rated Insufficient Reliable Evidence To Rate, meaning the evidence is not established.
The Evidence, Ingredient by Ingredient
Each card holds our notes on one ingredient, then its uses graded effective, likely effective or possibly effective.
Green Tea
From our Green Tea guide
- People use green tea for a wide range of reasons, but the strength of the evidence varies a lot depending on the use.
Research suggests a benefit for
- Hyperlipidemia and cardiovascular disease (CVD)
Not counted here: one graded use is for Green Tea injected or put on the skin (human papillomavirus (HPV)), not for a product like this one. Two more are for conditions treated by a doctor or in a hospital (endometrial cancer and ovarian cancer).
Every graded use, in the Green Tea guideGuarana
From our Guarana guide
- People most often take guarana to boost energy, fight tiredness, and improve focus and alertness.
- These effects are mostly explained by its caffeine, which is a well-known stimulant.
No use is graded effective, likely effective or possibly effective for it yet.
Every graded use, in the Guarana guideYerba Mate
From our Yerba Mate guide
- Yerba mate is most reliably useful as a source of caffeine, which can increase alertness and reduce feelings of tiredness.
- This stimulant effect is well known and is the main reason most people drink it.
No use is graded effective, likely effective or possibly effective for it yet.
Every graded use, in the Yerba Mate guideCaffeine
Our pharmacy team’s notes on Caffeine
- Caffeine has the strongest ratings here.
Research suggests a benefit for
- Athletic performance (the use on its label) and mental alertness
- Diabetes, obesity, memory and postdural puncture headache
Not counted here: one graded use is for Caffeine injected or put on the skin (bronchopulmonary dysplasia), not for a product like this one. Two more are for conditions treated by a doctor or in a hospital (neonatal apnea and postoperative headache).
Every graded use, in the Caffeine guideRed Raspberry
From our Red Raspberry guide
- The most popular use of red raspberry leaf is as a pregnancy and labor tonic, with the idea that it may tone the uterus and ease delivery.
- A few small studies have looked at this, but the results are mixed and the overall evidence is weak.
No use is graded effective, likely effective or possibly effective for it yet.
Every graded use, in the Red Raspberry guideGinkgo
From our Ginkgo guide
- Ginkgo is widely marketed for memory and brain function, but the research is mixed.
Research suggests a benefit for
- Anxiety, schizophrenia, premenstrual syndrome (PMS), vertigo and tardive dyskinesia
Not counted here: one graded use is for Ginkgo injected or put on the skin (hearing loss), not for a product like this one. Two more are for conditions treated by a doctor or in a hospital (vascular dementia and stroke).
Every graded use, in the Ginkgo guideVinpocetine
From our Vinpocetine guide
- Vinpocetine is most commonly used for memory, mental sharpness, and age-related cognitive decline.
Not counted here: one graded use is for a condition treated by a doctor or in a hospital (dementia).
Every graded use, in the Vinpocetine guideRhodiola
From our Rhodiola guide
- People use Rhodiola for many reasons, but the scientific evidence is mixed and most studies are small or of low quality.
No use is graded effective, likely effective or possibly effective for it yet.
Every graded use, in the Rhodiola guideThe grades are the Natural Medicines database’s, which we license; tap a grade for what it means. They are about each ingredient, not this exact product.
About Rivalus
Manufacturer and brand details for MPower, from the product label.
Rivalus has 43 products in our supplement database, 42 of them on the market, with labels on file since 2012. Our database is built from the NIH’s Dietary Supplement Label Database and our pharmacy team’s own additions, so it covers the labels filed there, not every product the brand sells.
- Web Address
- www.rivalus.net
MPower by Rivalus: Common Questions
Does MPower by Rivalus interact with any drugs?
What are the side effects of MPower by Rivalus?
Who should be careful taking MPower by Rivalus?
Can MPower by Rivalus affect the liver?
Can MPower by Rivalus affect the kidneys?
How can MPower by Rivalus interact with so many drugs?
Where does the information about MPower by Rivalus come from?
Is MPower by Rivalus safe to take while pregnant?
Does caffeine help with mental alertness?
Is ginkgo effective for dementia?
Is lactate effective for dry skin?
Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy
Still Have a Question About MPower?
Our pharmacists answer drug and supplement questions, free, by email.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and drugs.
Who Reviews This Page
The pharmacist behind it, and how it is checked.
Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist and founder of HelloPharmacist
A licensed pharmacist for more than 13 years, he built the system behind this page: it reads the label on file, matches each active ingredient to its record in the Natural Medicines database, checks those records against every drug we cover, and our pharmacy team writes the take and the interaction summary from those records.
- 13+ Years in PharmacyRetail and clinical pharmacy, medication safety and healthcare administration.
- Board Certified (BCPS)A pharmacotherapy specialist, certified by the Board of Pharmacy Specialties.
- Herbalist TrainingCertificates in medical ethnobotany, for the herbs and supplements people take.
Where This Page Comes From
MPower’s label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD)
- The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center)
- The evidence-graded clinical reference behind the ingredient interaction, evidence and safety records, which we license.
- HelloPharmacist Editorial Team
- Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.
- The Pharmacy Team’s Take and Summaries
- Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules. Clinical methodology reviewed by Dr. Brian Staiger, PharmD, BCPS. Last generated Oct 31, 2026. How we use AI
- The ratings in the Quick Summary
- They summarize available label information, ingredient evidence and known drug-safety records: a summary of what is known, not a grade of the product itself. They do not verify product identity, purity, potency, contamination or manufacturing quality. How these ratings are computed
The References Behind the Interaction Records
Every citation the ingredients’ records rest on is listed in that ingredient’s guide, in context: Lactic Acid, 21 references; Pyruvate, 5 references; Citric Acid, 10 references; Succinate, 3 references; Malic Acid, 7 references; Green Tea, 219 references; Guarana, 115 references; Yerba Mate, 124 references; Caffeine, 235 references; Red Raspberry, 8 references; Ginkgo, 97 references; Vinpocetine, 27 references; Rhodiola, 13 references .
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Keep Exploring
- Supplement interaction checkerCheck any supplement or product against your drugs
- Drug–drug interactionsCheck two or more of your drugs against each other
- Browse drugs A to ZEvery drug we have checked against herbs and supplements
- NDC and pricing lookupFind a drug’s NDCs, packaging and costs
- Ask a pharmacistA free, personal answer from our licensed team